Ameritas Investment Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$886K Sell
11,327
-328
-3% -$26.5K 0.02% 675
2026
Q1
$1.01M Hold
11,655
0.03% 600
2025
Q4
$1.12M Sell
11,655
-199
-2% -$19.3K 0.03% 559
2025
Q3
$1.13M Sell
11,854
-427
-3% -$39.3K 0.03% 567
2025
Q2
$1.07M Sell
12,281
-146
-1% -$12.4K 0.03% 596
2025
Q1
$1.12M Sell
12,427
-2,579
-17% -$231K 0.04% 576
2024
Q4
$1.2M Sell
15,006
-425
-3% -$36.8K 0.04% 563
2024
Q3
$1.39M Buy
15,431
+1,458
+10% +$123K 0.05% 511
2024
Q2
$1.1M Sell
13,973
-425
-3% -$34.8K 0.04% 587
2024
Q1
$1.25M Sell
14,398
-2,740
-16% -$234K 0.04% 539
2023
Q4
$1.41M Sell
17,138
-1,365
-7% -$104K 0.05% 469
2023
Q3
$1.45M Sell
18,503
-6,851
-27% -$574K 0.06% 400
2023
Q2
$2.23M Sell
25,354
-309
-1% -$26.6K 0.08% 249
2023
Q1
$2.07M Buy
25,663
+270
+1% +$22K 0.08% 273
2022
Q4
$2.05M Buy
25,393
+1,045
+4% +$84.7K 0.08% 281
2022
Q3
$1.96M Sell
24,348
-45
-0.2% -$4.04K 0.09% 240
2022
Q2
$2.19M Sell
24,393
-347
-1% -$35.2K 0.09% 216
2022
Q1
$2.74M Buy
24,740
+3,219
+15% +$340K 0.1% 211
2021
Q4
$2.23M Sell
21,521
-493
-2% -$57.1K 0.08% 294
2021
Q3
$2.76M Sell
22,014
-130
-0.6% -$16.8K 0.1% 204
2021
Q2
$2.75M Sell
22,144
-1,537
-6% -$193K 0.1% 211
2021
Q1
$2.79M Sell
23,681
-925
-4% -$108K 0.11% 193
2020
Q4
$2.88M Sell
24,606
-3,069
-11% -$338K 0.13% 166
2020
Q3
$2.88M Sell
27,675
-818
-3% -$82.1K 0.13% 148
2020
Q2
$2.61M Sell
28,493
-742
-3% -$71.2K 0.12% 147
2020
Q1
$2.63M Sell
29,235
-3,014
-9% -$321K 0.15% 115
2019
Q4
$3.66M Sell
32,249
-1,613
-5% -$177K 0.16% 96
2019
Q3
$3.68M Sell
33,862
-516
-2% -$53.8K 0.17% 97
2019
Q2
$3.35M Sell
34,378
-424
-1% -$38.7K 0.15% 115
2019
Q1
$3.17M Buy
34,802
+95
+0.3% +$8.5K 0.15% 115
2018
Q4
$3.16M Sell
34,707
-849
-2% -$79.3K 0.17% 105
2018
Q3
$3.5M Sell
35,556
-727
-2% -$67.2K 0.16% 116
2018
Q2
$3.1M Sell
36,283
-2,611
-7% -$218K 0.15% 124
2018
Q1
$3.12M Buy
38,894
+6,269
+19% +$517K 0.15% 129
2017
Q4
$3.26M Sell
32,625
-7,316
-18% -$586K 0.15% 136
2017
Q3
$3.19M Buy
39,941
+420
+1% +$34.9K 0.15% 121
2017
Q2
$3.51M Sell
39,521
-382
-1% -$32.2K 0.17% 102
2017
Q1
$3.21M Buy
39,903
+2,358
+6% +$184K 0.16% 117
2016
Q4
$2.67M Sell
37,545
-263
-0.7% -$20.7K 0.13% 158
2016
Q3
$3.27M Sell
37,808
-21,460
-36% -$1.87M 0.18% 103
2016
Q2
$5.14M Buy
59,268
+5,023
+9% +$406K 0.33% 51
2016
Q1
$4.07M Buy
54,245
+26,740
+97% +$2.01M 0.27% 64
2015
Q4
$2.12M Buy
27,505
+896
+3% +$67.4K 0.14% 158
2015
Q3
$1.78M Sell
26,609
-50
-0.2% -$3.68K 0.13% 185
2015
Q2
$1.98M Sell
26,659
-17,662
-40% -$1.35M 0.13% 180
2015
Q1
$3.46M Buy
44,321
+25,887
+140% +$1.96M 0.23% 86
2014
Q4
$1.33M Buy
18,434
+287
+2% +$19.9K 0.09% 216
2014
Q3
$1.12M Sell
18,147
-1,381
-7% -$87.8K 0.08% 261
2014
Q2
$1.25M Sell
19,528
-249
-1% -$15.1K 0.09% 244
2014
Q1
$1.22M Sell
19,777
-1,180
-6% -$68.7K 0.1% 245
2013
Q4
$1.2M Sell
20,957
-192
-0.9% -$10.9K 0.1% 254
2013
Q3
$1.13M Buy
+21,149
New +$1.14M 0.11% 243

Other funds holding MDT

Ameritas Investment Partners's MDT Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Medtronic (MDT) stake by 2.8% in Q2 2026, selling an estimated $26.5K and leaving 11,327 shares worth $886K. The position accounts for 0.02% of the portfolio, ranked #675.

Ameritas Investment Partners first reported a position in MDT in Q3 2013 and has held it in 52 quarters since. The position peaked at $5.14M in Q2 2016. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ameritas Investment Partners held 11,327 shares of Medtronic worth $886K as of Q2 2026.
  • Ameritas Investment Partners sold 328 Medtronic shares in Q2 2026, an estimated $26.5K.
  • Medtronic made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #675 holding.
  • Ameritas Investment Partners first reported a position in Medtronic in Q3 2013 and has held it in 52 quarters since.
  • Ameritas Investment Partners's Medtronic position peaked at $5.14M in Q2 2016.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.